DOI: 10.1056/NEJMoa2032183
Usage Comparisons A 2023 study published in BMJ (formerly the British Medical Journal) suggests tirzepatide the active ingredient in Mounjaro may outperform semaglutide in weight loss efficacy
Workout Analogy & Concentration (00:32:28) Aspiring Writers & Focused Hours
Given the small sample size, absence of a comparator group, lack of formal event adjudication, and limited statistical power, no conclusions regarding cardiovascular benefit or harm can be drawn
You can check the Mounjaro savings card, Ozempic savings card, Wegovy savings card, and Zepbound savings card or consider using the self-pay option provided by LillyDirect (Eli Lilly) or NovoCare Pharmacy (Novo Nordisk)
Not everyone experiences side effects at the same time